Correspondence to Dr Parastou Donyai, Reading School of Pharmacy, University of Reading, PO Box 226, Whiteknights, Reading RG6 6AP, UK; p.donyai{at}reading.ac.uk Background Pharmacy aseptic units ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone ...

PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto ...

That facility will be GMP ready this summer; since the plant’s 2022 groundbreaking, PCI has methodically developed aseptic-by-design processes as ... support the clinical- and commercial-scale final ...

For PCI’s advanced drug delivery systems and drug-device combination business, Althea’s assets supplement PCI’s leadership position in final device assembly and packaging facilities in both ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities ... position in final device assembly and packaging facilities in ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities for prefilled ... PCI’s leadership position in final device assembly and ...

Aseptic meningitis is when something other than a bacterial infection causes meningitis. Most often, it is the result of a virus. When someone has aseptic meningitis, the meninges become inflamed ...

In the latest episode of The Top Line, Chris Hayden of Fierce Pharma sits down with Mary Lou Glotzbach, senior manager of drug delivery partnerships at Grand River Aseptic Manufacturing (GRAM).